Stero Biotechs
Tel Aviv, Israel· Est.
CBD‑driven steroid‑sparing therapies for inflammatory and autoimmune diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
CBD‑driven steroid‑sparing therapies for inflammatory and autoimmune diseases.
ImmunologyInflammatory diseasesGastroenterologyDermatologyInfectious diseases
Technology Platform
Cannabidiol (CBD) used as a steroid‑sparing and immunomodulatory agent to reduce required steroid doses while maintaining therapeutic efficacy.
Opportunities
Broad steroid‑sparing application across multiple high‑volume autoimmune and inflammatory indications offers sizable market potential and partnership opportunities with pharma.
Risk Factors
Regulatory uncertainty for cannabis‑derived products, need for robust efficacy data across diverse indications, and competition from other CBD and steroid‑sparing developers.
Competitive Landscape
Competes with other CBD‑based therapeutics and traditional steroid‑sparing agents; differentiation lies in a patented, multi‑indication platform and early clinical evidence of dose reduction.